Nov 5 (Reuters) -
KAKEN PHARMACEUTICAL CO LTD
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Full year to Full year ended
Sep 30, 2009 Sep 30, 2008 Mar 31, 2010 Mar 31, 2009
LATEST YEAR-AGO COMPANY YEAR-AGO
H1 RESULTS H1 RESULTS FORECAST RESULTS
Sales 42.34 41.10 86.10
(+3.0 pct) (+3.8%)
Operating 6.06 5.94 11.30
(+2.1 pct) (+6.3%)
Recurring 5.81 5.80 10.80
(+0.2 pct) (+4.9%)
Net 3.52 3.41 6.50
(+3.1 pct) (+16.5%)
EPS Y35.82 Y33.67 Y66.21
Annual div Y30.00 Y26.00
-Q2 div Y15.00 Y13.00
-Q4 div Y13.00 Y15.00
NOTE - Kaken Pharmaceutical Co Ltd specialises in drugs for practitioners.
For latest earnings estimates made by Toyo Keizai, please
double click on 4521.TK1.
Healthcare